Thursday, August 13, 2020 | ePaper

US buys nearly all stocks of coronavirus drug remdesivir

  • Print
Al Jazeera :
The United States has bought nearly all the available global supplies for the next three months of anti-viral drug remdesivir, one of two drugs that have proven to be effective against COVID-19.
The US Department of Health Services (HHS) announced on Monday it had secured more than 500,000 treatment courses of remdesivir from drugmaker Gilead Sciences for US hospitals until September.
The stocks make up 100 percent of Gilead's projected production for July and 90 percent each for August and September.
"President [Donald] Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for COVID-19," HHS Secretary Alex Azar said in a statement.
"To the extent possible, we want to ensure that any American patient who needs remdesivir can get it." Remdesivir, which is administered intravenously in hospital, is the first drug to show improvement in COVID-19 patients in formal clinical trials, and new information about its efficacy is being closely watched around the world, as nations battle the coronavirus pandemic.
US FDA allows emergency use of remdesivir drug for coronavirus (2:15)
In May, US regulators allowed the emergency use of the experimental drug that appears to help some patients recover faster.
The drug has received full approval by Japanese health regulators. US approval requires a time-consuming Food and Drug Administration review, but Emergency Use Authorisations can be used in a health crisis when other options are not available.
There are currently no US approvals for treatments or vaccines for the new coronavirus that has infected more than 10 million people and killed nearly 500,000 worldwide, including more than 127,000 deaths in the US.
Dozens of companies are working on a variety of treatment and vaccine approaches.
Remdesivir, which previously failed as a treatment for Ebola, is designed to disable the mechanism by which certain viruses, including the new coronavirus, make copies of themselves and potentially overwhelm their host's immune system.
On Monday, Gilead said it would price remdesivir at $2,340 per patient in the US and other wealthier nations. In 127 poor or middle-income countries, Gilead is allowing generic makers to supply the drug.
Last month, according to initial findings, a cheap and widely-used steroid called dexamethasone was proven to save lives among critically ill COVID-19 patients in what scientists and the World Health Organization hailed as a breakthrough in the fight against the virus.

More News For this Category

Lebanese MPs meet for first time since blast

Lebanese MPs meet for first time since blast

Reuters: Lebanese security forces deployed heavily in Beirut on Thursday, stopping protesters from reaching a conference centre where MPs began meeting for the first time since the catastrophic chemicals explosion

Bangladesh opens a new unit to run DNA tests

Bangladesh opens a new unit to run DNA tests

The government has set up a new department to test and preserve DNA samples, six years after passing the law on the matter.The DNA Laboratory Management Department will operate under

Bangladesh reports 2,617 new virus cases, 44 deaths in a day

Bangladesh reports 2,617 new virus cases, 44 deaths in a day

Bangladesh has registered 44 new fatalities from the novel coronavirus in a daily count, taking the death toll to 3,557.The caseload surged to 269,115 after 2,617 people tested positive for

Ex-CJ Sinha, 10 others indicted over Farmers Bank scam

Ex-CJ Sinha, 10 others indicted over Farmers Bank scam

A Dhaka court has opened the trial of former chief justice SK Sinha and 10 others on charges of loan fraud and embezzlement of Tk 40 million from the Farmers

Dilly-dally Disbursement of package loans frustrates SMEs

Staff Reporter :Commercial banks are delaying to disburse loans from the stimulus package for the cottage, micro and small enterprises (CMS) in the name of inspection, entrepreneurs of the

Some patriotism and little bit of self-respect can change needed to live as free people

Some patriotism and little bit of self-respect can change needed to live as free people

Freedom is to be struggled and renewed everyday.After the daring killing of a retired Major Sinha Mohammad Rashed Khan we are feeling optimism now that there is a realisation

Bangladesh in no hurry to trial Chinese vaccine

News Desk :Bangladesh is in no hurry to start a late-stage human trial of a vaccine for the novel coronavirus, developed by China's Sinovac Biotech Ltd, according to the

HC resumes regular functions `Crowd in corridor has to be managed`

Staff Reporter :The Supreme Court has started its regular activities along with virtual system after long four and half months though coronavirus fear is not yet over. Long lines

Lawyers and justice seekers form a long queue at the ground floor of the High Court on Wednesday as regular court activities resume after a long break. This photo shows that crowd stand there with total disregard to social distancing norms.

Lawyers and justice seekers form a long queue at the ground floor of the High Court on Wednesday as regular court activities resume after a long break. This photo shows that crowd stand there with total disregard to social distancing norms.

.

OC Pradeep among 29 others sued in another murder case

Staff Reporter :Former OC of Teknaf Police Station Pradeep Kumar Das, an accused in sensational Major (Retd) Sinha Mohammad Rashed Khan murder case, and 28 other people have been